• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconValeant

Valeant

Page 9 of 12
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Leadership
Valeant CEO J. Michael Pearson Hospitalized for ‘Severe’ Pneumonia
By ReutersDecember 26, 2015
Light snow falls on the Dow Chemical Co. Michigan Operations
Leadership
Shortchanging The Future
By Alan MurrayDecember 21, 2015
Janet Yellen Testifies Before House Financial Services Committee
Finance
End of Easy Money Brings Relief
By Alan MurrayDecember 17, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Says Board Is ‘Welcome to Fire Me’
By Jen WiecznerDecember 16, 2015
Oil Patch Woe and Fed Decision Looms–5 Things to Know Today
Tech
Oil Patch Woe and Fed Decision Looms–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithDecember 16, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
Health
Valeant Has Hired a Crisis Management Firm
By ReutersDecember 14, 2015
Cindy Whitehead, chief executive officer of Sprout Pharmaceuticals Inc., speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, Aug. 19, 2015. Whitehead discussed Addyi, the company's pill for low libido in women that won approval from the U.S. Food and Drug Administration yesterday. Photographer: Chris Goodney/Bloomberg *** Local Caption *** Cindy Whitehead
MPW
CEO Behind ‘Female Viagra’ Leaves Company After Valeant Purchase
By Laura LorenzettiDecember 10, 2015
This Is What Happens When Cheap Drugs Get Wildly Expensive
Health
This Is What Happens When Cheap Drugs Get Wildly Expensive
By Laura LorenzettiDecember 9, 2015
Key Speakers At The Bloomberg Markets Most Influential Summit
Finance
Bill Ackman Just Boosted His Valeant Stake
By ReutersNovember 24, 2015
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
Finance
Novartis Agrees to $390 Million Settlement
By Jen WiecznerNovember 20, 2015
Police Operation in Saint Denis
Tech
Paris Siege and Square Prices IPO–5 Things to Know Today
By Laura Lorenzetti and Geoffrey SmithNovember 18, 2015
Flibanserin
Health
Why ‘Female Viagra’ Is Not Selling
By Robert HackettNovember 17, 2015
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Leadership
Mylan, Valeant and Theranos: What the Heck, Biotech?
By Jeffrey SonnenfeldNovember 13, 2015
Bill Ackman
Health
Valeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance
Valeant CEO Defends Firm but Says He Doesn’t Have ‘Full Knowledge’
By Stephen GandelNovember 10, 2015
1...
  • 7
  • 8
  • 9
  • 10
  • 11
12
Most Popular
Cybersecurity
OpenAI says its AI models secretly broke out of a secure test environment and hacked into AI company Hugging Face in order to cheat on an evaluationplaceholder alt text
By Jeremy Kahn and Emily ForliniJuly 21, 2026
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stockplaceholder alt text
By Sasha RogelbergJuly 20, 2026
AI
Mathematicians grapple with a ‘very rapid and very unsettling change’ as AI cracks yet another century-old problemplaceholder alt text
By Eva RoytburgJuly 21, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.